Oncomembrane, Inc.
5Patents
0Active
5Granted
28Portfolio score
Filing activity: Apr 11, 1994 → May 13, 1996
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5627171A | Sphingosine-1-phosphate/trimethylsphingosine composition | Human Necessities | 34 | Expired |
| US5663404A | Sphingosine-1-phosphate essentially free of L-threo isomer | Chemistry; Metallurgy | 22 | Expired |
| US5677189A | Method for quantifying sphingosine and for diagnosing platelet activation | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6031135A | Trimethylsphingosine derivatives | Human Necessities | 1 | Expired |
| US5693620A | Plasmalopsychosines and plasmalocerebrosides | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.